Alpa Laboratories Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting
11-02-2026 | 12:35 pm
11-02-2026 | 12:35 pm
Alpa Laboratories' board approved consolidated Q3 and 9M financial results. For the quarter ended Dec 31, 2025, revenue was ₹29.05 Cr, profit ₹1.90 Cr, and EPS ₹0.90. For the nine-month period, revenue hit ₹74.41 Cr, profit ₹13.78 Cr, and EPS ₹6.55.
No comments yet. Be the first to comment!
